Dickson NR - Search Results

1

Impact of clinical pathways on treatment patterns and outcomes for patients with non-small-cell lung cancer: real-world evidence from a community oncology practice.

Dickson NR, Beauchamp KD, Perry TS, Roush A, Goldschmidt D, Edwards ML, Blakely LJ. Dickson NR, et al. J Comp Eff Res. 2022 Jun;11(8):609-619. doi: 10.2217/cer-2021-0290. Epub 2022 May 12. J Comp Eff Res. 2022. PMID: 35546311 Free article.

2

A phase I/II study of exisulind in combination with docetaxel/carboplatin in patients with metastatic non-small-cell lung cancer.

Jones SF, Kuhn JG, Greco FA, Raefsky EL, Hainsworth JD, Dickson NR, Thompson DS, Willcutt NT, White MB, Burris HA 3rd. Jones SF, et al. Among authors: dickson nr. Clin Lung Cancer. 2005 May;6(6):361-6. doi: 10.3816/clc.2005.n.016. Clin Lung Cancer. 2005. PMID: 15943897 Clinical Trial.

3

Single-agent gefitinib in patients with untreated advanced non-small-cell lung cancer and poor performance status: a Minnie Pearl Cancer Research Network Phase II Trial.

Spigel DR, Hainsworth JD, Burkett ER, Burris HA, Yardley DA, Thomas M, Jones SF, Dickson NR, Scullin DC, Bradof JE, Rubinsak JR, Brierre JE, Greco FA. Spigel DR, et al. Among authors: dickson nr. Clin Lung Cancer. 2005 Sep;7(2):127-32. doi: 10.3816/CLC.2005.n.028. Clin Lung Cancer. 2005. PMID: 16179100 Clinical Trial.

4

Safety of antiemetic prophylaxis with HTX-019 as a 30-min infusion in patients with cancer: a retrospective study.

Perry TS, Dickson N, Patton JF. Perry TS, et al. Future Oncol. 2020 Mar;16(7):263-268. doi: 10.2217/fon-2019-0835. Epub 2020 Jan 27. Future Oncol. 2020. PMID: 31984777 Free article.

5

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting.

Mason C, Ellis PG, Lokay K, Barry A, Dickson N, Page R, Polite B, Salgia R, Savin M, Shamah C, Socinski MA. Mason C, et al. J Clin Pathw. 2018 Jan-Feb;4(1):49-54. doi: 10.25270/jcp.2018.02.00001. J Clin Pathw. 2018. PMID: 31453358 Free PMC article.

6

Time to Rethink the Role of Clinical Pathways in the Era of Precision Medicine: A Lung Cancer Case Study.

Schleicher SM, Chaudhry B, Dickson NR, Aviki E, Arrowsmith E, Parikh RB, Yue AT, Connor N, Schwartzberg L, Lyss AJ. Schleicher SM, et al. Among authors: dickson nr. JCO Oncol Pract. 2021 Jul;17(7):379-381. doi: 10.1200/OP.21.00073. Epub 2021 Apr 19. JCO Oncol Pract. 2021. PMID: 33872069 No abstract available.

7

Insights From the Oncology Care First Proposal-Where We've Been and Where We're Going in Value-Based Care.

Young G, Schleicher SM, Dickson NR, Lyss AJ. Young G, et al. Among authors: dickson nr. JCO Oncol Pract. 2020 Apr;16(4):151-153. doi: 10.1200/JOP.20.00015. Epub 2020 Feb 25. JCO Oncol Pract. 2020. PMID: 32097082 No abstract available.

8

American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.

Pennell NA, Dillmon M, Levit LA, Moushey EA, Alva AS, Blau S, Cannon TL, Dickson NR, Diehn M, Gonen M, Gonzalez MM, Hensold JO, Hinyard LJ, King T, Lindsey SC, Magnuson A, Marron J, McAneny BL, McDonnell TM, Mileham KF, Nasso SF, Nowakowski GS, Oettel KR, Patel MI, Patt DA, Perlmutter J, Pickard TA, Rodriguez G, Rosenberg AR, Russo B, Szczepanek C, Smith CB, Srivastava P, Teplinsky E, Thota R, Traina TA, Zon R, Bourbeau B, Bruinooge SS, Foster S, Grubbs S, Hagerty K, Hurley P, Kamin D, Phillips J, Schenkel C, Schilsky RL, Burris HA 3rd. Pennell NA, et al. Among authors: dickson nr. J Clin Oncol. 2021 Jan 10;39(2):155-169. doi: 10.1200/JCO.20.02953. Epub 2020 Dec 8. J Clin Oncol. 2021. PMID: 33290128

9

Telehealth in Oncology: ASCO Standards and Practice Recommendations.

Zon RT, Kennedy EB, Adelson K, Blau S, Dickson N, Gill D, Laferriere N, Lopez AM, Mulvey TM, Patt D, Pickard TA, Purdom T, Royce TJ, Sumrall AL, Page RD. Zon RT, et al. JCO Oncol Pract. 2021 Sep;17(9):546-564. doi: 10.1200/OP.21.00438. Epub 2021 Jul 28. JCO Oncol Pract. 2021. PMID: 34319760

10

Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial.

Yardley DA, Dickson N, Drosick D, Earwood C, Inhorn R, Murphy P, Hainsworth JD. Yardley DA, et al. Clin Breast Cancer. 2016 Jun;16(3):180-7. doi: 10.1016/j.clbc.2016.02.003. Epub 2016 Feb 12. Clin Breast Cancer. 2016. PMID: 26943991 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page